MASCC: FEBRILE NEUTROPENIA RISK INDEX SCORE

Febrile neutropenia (FN) 

FN is a life-threatening complication of cancer chemotherapy. The classical aproach is hospitalize patients to administer broad-spectrum antibiotics intravenously. Most patients respond promptly with no complications.

The MASCC Risk Index is a scoring system for identifying low-risk cancer patients with febrile neutropenia. It could be useful to select patients for testing more convenient or cost-effective therapies.

MASCC Risk Index Factors and Weights